Massachusetts Selecta Biosciences' CEO to Retire at the End of 2018 Post author:Sam Post published:January 1, 2018 Post category:BioPharma Werner Cautreels, Ph.D., intends to retire effective December 31, 2018. Source: BioSpace You Might Also Like Ultragenyx Announces Burosumab Data Presentations At Annual Meeting August 23, 2017 Auris Medical Fails Again in Phase III Trial March 13, 2018 Marinus Pharma Provides Business Update And 2016 Financial Results March 12, 2017
